WASHINGTON, May 23, 2023 /PRNewswire/ — IMiracle Shenzhen Technology Co. Ltd. today issued the following statement regarding placement of its products on the FDA’s Import Alert # 98-06: “IMiracle is disappointed by the U.S. Food and Drug Administration’s (FDA) decision to abruptly and…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.